Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platinum-Based Chemotherapy With Vitamin Supplementation in Non-Small Cell Lung Cancer
2005-002736-10Phase 3Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cisplatin in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Royal Marsden NHS Foundation Trust. Primary endpoints: Incidence of neutropenia, Incidence of mucositis and 2 more. Started Nov 2005; status: completed.
02
Drugs
cisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2005-002736-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002736-10.